Summary
A comprehensive episode on vitamin C science. Covers oral bioavailability vs intravenous, immune cell function, effects on common cold and viral infections, lung function benefits, sepsis and pneumonia applications, inflammation, IV vitamin C in cancer treatment, the debate about whether vitamin C blunts exercise adaptation, vitamin C's role in fatty acid oxidation and obesity, brain effects on memory and cognition, cardiovascular health, and safety considerations including kidney stone risk.
Key Points
- Oral vitamin C has limited bioavailability compared to intravenous
- Vitamin C improves lung function and supports immunity against viral infections
- The debate continues on whether vitamin C supplementation blunts exercise adaptations
- IV vitamin C is being studied as adjunct therapy for certain cancers and infections
- Vitamin C plays a role in fatty acid oxidation with relevance to obesity
- High-dose vitamin C may increase kidney stone risk in susceptible individuals
Key Moments
IV vitamin C as a cancer therapeutic strategy
IV vitamin C achieves plasma levels far beyond oral dosing, showing promise as a therapeutic strategy against cancer and serious illness.
"Although it's not the typical means of getting this essential vitamin, it offers promise as a therapeutic strategy against cancer and some other serious health concerns."
Immune cells concentrate vitamin C 50-100x plasma
Neutrophils hold 50-100x more vitamin C than plasma, serving as a potent antioxidant shield during immune response.
"Vitamin C is highly concentrated in immune cells, with neutrophils and leukocytes having 50 to 100 times higher vitamin C concentrations than plasma."
Related Research
Intravenous Vitamin C and Cancer: A Systematic Review.
Systematic review of 37 studies found IV vitamin C in cancer patients appears safe and may improve quality of life and reduce chemotherapy side effects, but high-quality efficacy evidence remains limited.
Effect of IV High-Dose Vitamin C on Mortality in Patients With Sepsis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Meta-analysis of 11 RCTs (1,737 patients) found high-dose IV vitamin C in sepsis was not associated with lower short-term mortality but significantly shortened vasopressor duration.
Vitamin C for preventing and treating the common cold
Cochrane review found regular vitamin C supplementation reduced cold duration by 8% in adults and 14% in children, but did not prevent colds in the general population.
The outcome of IV vitamin C therapy in patients with sepsis or septic shock: a meta-analysis of randomized controlled trials.
IV vitamin C reduced short-term mortality and ICU length of stay in sepsis and septic shock patients, with greater benefits seen in higher-dose protocols.
IV Vitamin C in Sepsis: A Latest Systematic Review and Meta-Analysis.
IV vitamin C significantly reduced overall mortality and 28-day mortality in sepsis patients but did not improve 30-day or 90-day mortality.
The effects of vitamin C supplementation in the critically ill patients outcomes: A systematic review and meta-analysis of randomized controlled trials.
Vitamin C supplementation in critically ill patients reduced ICU and hospital length of stay and duration of mechanical ventilation, but did not significantly reduce mortality.
Intravenous vitamin C monotherapy in critically ill patients: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis.
Meta-analysis with trial sequential analysis of 16 RCTs (2,130 patients) found IV vitamin C monotherapy significantly reduced overall mortality in critically ill patients (RR 0.73), with greatest benefit in higher-risk populations.
Vitamin C pharmacokinetics: implications for oral and intravenous use
NIH study showing oral vitamin C saturates at ~200mg doses, while higher oral doses are poorly absorbed - explaining why IV vitamin C achieves much higher blood levels.
Vitamin C and immune function
Comprehensive review established vitamin C's essential roles in immune function, with deficiency impairing immunity and supplementation potentially beneficial during infection.
